Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1636 studies found for:    "Squamous cell carcinoma"
Show Display Options
Download search resultsDownload the search results for:
"Squamous cell carcinoma" (1636 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed Aggressive Squamous Cell Carcinoma in Organ Transplant Recipients
Condition: Squamous Cell Carcinoma
Intervention:
2 Not yet recruiting Alpha Radiation Emitters Device for the Treatment of Squamous Cell Carcinoma
Condition: Squamous Cell Carcinoma
Intervention: Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)
3 Completed Nedaplatin (Jiebaishu®) Combined With Docetaxel for Advanced Lung Squamous Cell Carcinoma
Condition: Squamous Cell Carcinoma
Interventions: Drug: Nedaplatin;   Drug: Cisplatin;   Drug: Docetaxel
4 Not yet recruiting PEmbrolizumab Combined With Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck
Conditions: Squamous Cell Carcinoma of the Head and Neck;   Squamous Cell Carcinoma
Interventions: Drug: Pembrolizumab;   Radiation: Radiotherapy;   Drug: Chemotherapy
5 Completed
Has Results
Erlotinib in Women With Squamous Cell Carcinoma of the Vulvar
Condition: Squamous Cell Carcinoma
Intervention: Drug: Erlotinib
6 Active, not recruiting Treatment De-Intensification for Squamous Cell Carcinoma of the Oropharynx
Condition: Squamous Cell Carcinoma of Oropharynx
Interventions: Radiation: IMRT;   Drug: Cisplatin;   Drug: Carboplatin
7 Active, not recruiting Nimotuzumab in Combination With Chemoradiation for Local Advanced Esophageal Squamous Cell Carcinoma
Condition: Squamous Cell Carcinoma
Interventions: Drug: Nimotuzumab;   Drug: Placebo;   Drug: cisplatin;   Radiation: Radiotherapy
8 Terminated
Has Results
Temsirolimus (Torisel®) and Erlotinib (Tarceva®) in Platinum-Refractory/Ineligible, Advanced, Squamous Cell Carcinoma
Condition: Squamous Cell Carcinoma
Interventions: Drug: Erlotinib;   Drug: Temsirolimus
9 Recruiting A Pilot for a Case-Control Study of Esophageal Squamous Cell Carcinoma in Western Kenya
Condition: Esophageal Squamous Cell Carcinoma
Intervention:
10 Recruiting Trial of Pembrolizumab for Advanced Penile Squamous Cell Carcinoma
Condition: Penile Squamous Cell Carcinoma
Intervention: Drug: Pembrolizumab
11 Recruiting Apatinib and Irinotecan Combination Treatment in Esophageal Squamous Cell Carcinoma
Condition: Esophageal Squamous Cell Carcinoma
Interventions: Drug: Apatinib;   Drug: Irinotecan
12 Suspended Neoadjuvant Treatment of Nimotuzumab With Chemotherapy or Radiotherapy in Resectable Esophageal Squamous Cell Carcinoma
Condition: Esophageal Squamous Cell Carcinoma
Interventions: Drug: Nimotuzumab;   Drug: Paclitaxel;   Drug: Cisplatin;   Radiation: Radiation;   Procedure: Surgery
13 Completed Efficacy of AFL-assisted PDT in Microinvasive Squamous Cell Carcinoma
Condition: Microinvasive Squamous Cell Carcinoma
Interventions: Drug: lidocaine-prilocaine 5% cream application;   Device: 2940-nm Er:YAG AFL pretreatment;   Drug: methyl-aminolevulinate application;   Device: Illuminating using red light-emitting diode lamps
14 Unknown  Pemetrexed as Salvage Treatment in Squamous Cell Carcinoma of Head and Neck
Condition: Squamous Cell Carcinoma of Head and Neck
Intervention: Drug: Pemetrexed
15 Completed
Has Results
Warning Signs of Squamous Cell Carcinoma and Prevention of SCC by at Risk Organ Transplant Recipients
Condition: Squamous Cell Carcinoma
Interventions: Behavioral: Educational Intervention;   Behavioral: Placebo
16 Active, not recruiting Fluorine F 18 EF5 Positron Emission Tomography in Assessing Hypoxia in Patients With Newly Diagnosed Stage I, Stage II, Stage III, or Stage IV Head or Neck Squamous Cell Cancer of the Oral Cavity, Oropharynx, and Larynx
Condition: Squamous Cell Carcinoma
Interventions: Drug: fluorine F18 EF5;   Procedure: immunohistochemistry staining method;   Procedure: biopsy;   Procedure: Positron Emission tomography
17 Recruiting Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma
Condition: Esophageal Squamous Cell Carcinoma Resectable
Intervention: Drug: Nimotuzumab combined with paclitaxel and cisplatin
18 Completed Prognostic Factor Analysis in Metastatic Esophageal Squamous Cell Carcinoma
Condition: Metastatic Esophageal Squamous Cell Carcinoma
Intervention:
19 Recruiting Survival Benefit of Elective Neck Dissection in T1,2N0M0 Oral Squamous Cell Carcinoma
Condition: Oral Squamous Cell Carcinoma
Intervention: Procedure: elective neck dissection
20 Recruiting Head and Neck Squamous Cell Carcinoma (HNSCC)PET-CT Pilot Study
Condition: Head and Neck Squamous Cell Carcinoma
Intervention: Drug: 18-F FDG

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.